Skip to main content

Peer Review reports

From: Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report

Original Submission
25 Apr 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
16 Jun 2016 Editorially accepted
7 Jul 2016 Article published 10.1186/s12885-016-2463-2

You can find further information about peer review here.

Back to article page